Miguel Angel Luque-Fernandez

Dr. Miguel Angel Luque-Fernandez

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2020 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HFHelen Fowler
Helen Fowler
ABAurelien Belot
Aurelien Belot
LELibby Ellis
Libby Ellis
CMCamille Maringe
Camille Maringe
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
BRBernard Rachet
Bernard Rachet
Background: The presence of comorbidity affects the care of cancer patients, many of whom are living with multiple comorbidities. The prevalence of cancer comorbidity, beyond summary metrics, is not well known. This study aims to estimate the prevalence of comorbid conditions among cancer patients in England, and describe the association between cancer comorbidity and socio-economic position, using population-based electronic health records. Methods: We linked England cancer registry records of patients diagnosed with cancer of the colon, rectum, lung or Hodgkin lymphoma between 2009 and 2013, with hospital admissions records. A comorbidity was any one of fourteen specific conditions, diagnosed during hospital admission up to 6 years prior to cancer diagnosis. We calculated the crude and age-sex adjusted prevalence of each condition, the frequency of multiple comorbidity combinations, and used logistic regression and multinomial logistic regression to estimate the adjusted odds of having each condition and the probability of having each condition as a single or one of multiple comorbidities, respectively, by cancer type. Results: Comorbidity was most prevalent in patients with lung cancer and least prevalent in Hodgkin lymphoma patients. Up to two-thirds of patients within each of the four cancer patient cohorts we studied had at least one comorbidity, and around half of the comorbid patients had multiple comorbidities. Our study highlighted common comorbid conditions among the cancer patient cohorts. In all four cohorts, the odds of having a comorbidity and the probability of multiple comorbidity were consistently highest in the most deprived cancer patients. Conclusions: Cancer healthcare guidelines may need to consider prominent comorbid conditions, particularly to benefit the prognosis of the most deprived patients who carry the greater burden of comorbidity. Insight into patterns of cancer comorbidity may inform further research into the influence of specific comorbidities on socio-economic inequalities in receipt of cancer treatment and in short-term mortality.

7 November 2017 in Annals of Internal Medicine
Verified
Journal Article
Closed access
JBJenifer M. Brown
Jenifer M. Brown
CRCassianne Robinson-Cohen
Cassianne Robinson-Cohen
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
MAMatthew A. Allison
Matthew A. Allison
RBRene Baudrand
Rene Baudrand
AVAnand Vaidya
Anand Vaidya
Primary aldosteronism is the most common and modifiable form of secondary hypertension and is usually considered when the classic phenotype of severe hypertension or hypokalemia is encountered. Thi... Background: Primary aldosteronism is recognized as a severe form of renin-independent aldosteronism that results in excessive mineralocorticoid receptor (MR) activation. Objective: To investigate w...

13 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
GCGilles Van Cutsem
Gilles Van Cutsem
EGEric Goemaere
Eric Goemaere
KHKatherine Hilderbrand
Katherine Hilderbrand
MSMichael Schomaker
Michael Schomaker
ABAndrew Boulle
Andrew Boulle
Innovative models of care are required to cope with the ever-increasing number of patients on antiretroviral therapy in the most affected countries. This study, in Khayelitsha, South Africa, evaluates the effectiveness of a group-based model of care run predominantly by non-clinical staff in retaining patients in care and maintaining adherence. Participation in “adherence clubs” was offered to adults who had been on ART for at least 18 months, had a current CD4 count >200 cells/ml and were virologically suppressed. Embedded in an ongoing cohort study, we compared loss to care and virologic rebound in patients receiving the intervention with patients attending routine nurse-led care from November 2007 to February 2011. We used inverse probability weighting to estimate the intention-to-treat effect of adherence club participation, adjusted for measured baseline and time-varying confounders. The principal outcome was the combination of death or loss to follow-up. The secondary outcome was virologic rebound in patients who were virologically suppressed at study entry. Of 2829 patients on ART for >18 months with a CD4 count above 200 cells/µl, 502 accepted club participation. At the end of the study, 97% of club patients remained in care compared with 85% of other patients. In adjusted analyses club participation reduced loss-to-care by 57% (hazard ratio [HR] 0.43, 95% CI = 0.21–0.91) and virologic rebound in patients who were initially suppressed by 67% (HR 0.33, 95% CI = 0.16–0.67). Patient adherence groups were found to be an effective model for improving retention and documented virologic suppression for stable patients in long term ART care. Out-of-clinic group-based models facilitated by non-clinical staff are a promising approach to assist in the long-term management of people on ART in high burden low or middle-income settings.

23 April 2018 in Statistics in Medicine
Verified
Journal Article
Open access
PDF file
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
MSMichael Schomaker
Michael Schomaker
BRBernard Rachet
Bernard Rachet
MSMireille E. Schnitzer
Mireille E. Schnitzer
When estimating the average effect of a binary treatment (or exposure) on an outcome, methods that incorporate propensity scores, the G‐formula, or targeted maximum likelihood estimation (TMLE) are preferred over naïve regression approaches, which are biased under misspecification of a parametric outcome model. In contrast propensity score methods require the correct specification of an exposure model. Double‐robust methods only require correct specification of either the outcome or the exposure model. Targeted maximum likelihood estimation is a semiparametric double‐robust method that improves the chances of correct model specification by allowing for flexible estimation using (nonparametric) machine‐learning methods. It therefore requires weaker assumptions than its competitors. We provide a step‐by‐step guided implementation of TMLE and illustrate it in a realistic scenario based on cancer epidemiology where assumptions about correct model specification and positivity (ie, when a study participant had 0 probability of receiving the treatment) are nearly violated. This article provides a concise and reproducible educational introduction to TMLE for a binary outcome and exposure. The reader should gain sufficient understanding of TMLE from this introductory tutorial to be able to apply the method in practice. Extensive R‐code is provided in easy‐to‐read boxes throughout the article for replicability. Stata users will find a testing implementation of TMLE and additional material in the Appendix S1 and at the following GitHub repository: https://github.com/migariane/SIM‐TMLE‐tutorial

18 October 2016 in Annals of Internal Medicine
Verified
Journal Article
Closed access
DLDiana Lopez
Diana Lopez
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
ASAmy Steele
Amy Steele
GAGail K. Adler
Gail K. Adler
ATAlexander Turchin
Alexander Turchin
AVAnand Vaidya
Anand Vaidya
Adrenal tumors are frequent incidental findings on abdominal imaging done for unrelated indications. These tumors are deemed nonfunctional and assumed to be of no consequence if hormone levels are ... Background: Benign adrenal tumors are commonly discovered on abdominal imaging. Most are classified as nonfunctional and are considered to pose no health risk, but some are considered functional be...

1 February 2009 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
ABAriane Bauernfeind
Ariane Bauernfeind
JJJulio Díaz Jiménez
Julio Díaz Jiménez
CGCristina Linares Gil
Cristina Linares Gil
NONathalie El Omeiri
Nathalie El Omeiri
DGDionisio Herrera Guibert
Dionisio Herrera Guibert
In this study, we aimed to describe the evolution of three cholera epidemics that occurred in Lusaka, Zambia, between 2003 and 2006 and to analyse the association between the increase in number of cases and climatic factors. A Poisson autoregressive model controlling for seasonality and trend was built to estimate the association between the increase in the weekly number of cases and weekly means of daily maximum temperature and rainfall. All epidemics showed a seasonal trend coinciding with the rainy season (November to March). A 1 degrees C rise in temperature 6 weeks before the onset of the outbreak explained 5.2% [relative risk (RR) 1.05, 95% CI 1.04-1.06] of the increase in the number of cholera cases (2003-2006). In addition, a 50 mm increase in rainfall 3 weeks before explained an increase of 2.5% (RR 1.02, 95% CI 1.01-1.04). The attributable risks were 4.9% for temperature and 2.4% for rainfall. If 6 weeks prior to the beginning of the rainy season an increase in temperature is observed followed by an increase in rainfall 3 weeks later, both exceeding expected levels, an increase in the number of cases of cholera within the following 3 weeks could be expected. Our explicative model could contribute to developing a warning signal to reduce the impact of a presumed cholera epidemic.